HRT FINANCIAL LP

Position in IONS — Ionis Pharmaceuticals Inc

CIK 1475597 NEW YORK, NY

Position in IONS

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$18,941,452

+$17,127,618 QoQ

Shares Held

252,250

+1000.2% QoQ

Ownership

0.153%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $416,760,191 across 198 Biotechnology names. IONS ranks #4 (4.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	128,633	$42,560,800
2	IBRX	ImmunityBio, Inc.	3,925,446	$30,108,170
3	EXEL	Exelixis, Inc.	460,585	$19,754,490
4	IONS	Ionis Pharmaceuticals Inc This page	252,250	$18,941,452
5	MRNA	Moderna, Inc.	368,421	$18,715,786
6	ARGX	Argenx SE	18,754	$13,695,108
7	RARE	Ultragenyx Pharmaceutical Inc.	613,229	$12,847,147
8	IOVA	Iovance Biotherapeutics, Inc.	3,486,299	$12,236,909

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$18,941,452	252,250	+1000.2%	Shares	Defined	2026-05-14
2025-12-31	$1,813,834	22,928	-11.2%	Shares	Defined	2026-02-12
2025-03-31	$779,110	25,824	-83.8%	Shares	Defined	2025-05-15
2024-06-30	$7,610,587	159,685	+140.1%	Shares	Defined	2024-08-12
2024-03-31	$2,882,905	66,503	-42.0%	Shares	Defined	2024-05-13
2023-09-30	$5,198,256	114,600	+1990.1%	Shares	Defined	2023-11-13
2023-06-30	$224,967	5,483	-95.5%	Shares	Defined	2023-08-11
2022-06-30	$4,549,646	122,897	+12.4%	Shares	Defined	2022-08-12
2022-03-31	$4,051,287	109,376	-14.6%	Shares	Defined	2022-05-16
2021-09-30	$4,296,037	128,087	+164.5%	Shares	Defined	2021-11-15
2020-12-31	$2,738,062	48,427	+124.0%	Shares	Defined	2021-02-16
2020-06-30	$1,274,951	21,624	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.